期刊文献+

头孢菌素对凝血功能影响的体外研究 被引量:16

In vitro study on the effect of cephalosporin on coagulation
下载PDF
导出
摘要 目的探讨头孢菌素类抗生素对凝血功能的影响。方法测定正常混合血浆和各浓度梯度含抗生素血浆的PT、APTT、FIB、TT及FaⅡ。比较各浓度含抗生素血浆组与正常混合血浆组的测定结果之间的差异,并对凝血检测结果与抗生素的浓度作线性回归。结果血浆中头孢硫脒浓度达100、200、800、1600、100mg/L时,或头孢西丁钠浓度达800、400、1600、3200、200mg/L时,或头孢噻肟钠浓度达800、3200、1600、1600、200mg/L时,PT、APTT、FIB、TT及FaⅡ的测定结果与正常混合血浆结果之间的差异具有统计学意义。五项测定结果与血浆中的抗生素浓度存在线性关系。结论在体外实验中,头孢菌素类抗生素可以影响凝血检测结果。 Objective To study the effect of cephalosporin on coagulation. Methods PT, APTT, FIB, TT and FaⅡ of normal combining plasma and antibiotic plasma were detected. Results of normal combing plasma were compared and analyzed with the results of antibiotic plasma. The relationship of coagulation detection results and antibiotic concentrations were analyzed with linear regression analysis. Results PT, APTT, FIB, TT, FaⅡ values of blood plasma which containing 100, 200, 800, 1600, 100mg/L cefathiamidine, or 800, 400, 1600, 3200, 200mg/ L cefoxitin sodium, or 800, 3200, 1600, 1600, 200mg/L cefotaxime sodium are significantly different with those results of normal combining plasma. There's a linear relation between all of the five detection results and antibiotic concentrations. Conclusion Cephalosporin could effect cogulation analyzing results in vitro.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第5期379-382,I0003,共5页 Chinese Journal of Antibiotics
关键词 头孢菌素 凝血酶原时间(PT) 活化部分凝血活酶时间(APTT)纤维蛋白原(FIB) 凝血酶时间(TT) 凝血因子Ⅱ(FaⅡ) Cephalosporin Prothrombin time Activated partial thromboplastin time Fibrinogen Thrombin time Coagulation factor
  • 相关文献

参考文献4

二级参考文献13

  • 1Harold C. Safety of cefepime :a new extended-spectrum parenteral cephalosporin. Am J Med,1996,100(Suppl 6A) :68s-75s.
  • 2Comely OA, Bethe U, Seifert H, et al. A randomized monocentric trial in febrile neutropen patients:ceftriaxone and gentamicin vs cdepime and gentamicin. Ann Hemato1,2002 ,81:37-43.
  • 3Egerer G, Goldschwidt H, Streich N, et al. Cegtutidinm in combination with glycopeptide antibiotic is an effetive first-fine therapy for patients undergoing hige-dose therapy with autologous peripheral blood stem cell support. Support Care Cancer, 1999,7:336-342.
  • 4Jones RN. Hemorrhagic complications of cephalospofin therapy. Antimicro Newsletter, 1988.12 : 85 -89.
  • 5Giancarlo A,Albano DF,Pasquale P,et al. Cephalospvain-induced hypoprothrombinemia:ls the N-methylthiotetrazole side chain the culprit?Antimicro Agents Chemothera, 1986,29 : 1108-1109.
  • 6Schafer H,Naber K,Adam D. Hemostasis distttrbanee caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study. Arzneimittelforshung, 1989,39 : 1156-1162.
  • 7Gabryelewice A, Prokopawicz J, Wolosowicz N, et al. Changes in some hemostatic parameters in patients with infections treated with cefttaidime and latamoxef. Folia Haemotol Int Meg Klin Morphol Blufforsh, 1987,114:398-407.
  • 8Weitekamp MR,Caputo GM,Al-Mondhlry HR,et al. The effects of cefoperazone on plate.let ruction and coagulation in normal volunteers. J Antimicro Chemother, 1985,16:95-101.
  • 9Weitekamp MR, Abet RC. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA, 1983,249: 69-71.
  • 10胡丕华,国外药学抗生素分册,1990年,11卷,2期,116页

共引文献53

同被引文献96

引证文献16

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部